Recursion Pharmaceuticals reported 2 insider transactions totaling $97,222.74. Activity consisted of 1 tax payment of $18,400.36 and 1 sale of $78,822.38. Average transaction value was $48,611.37 ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

RXRX is trading in the middle of its 52-week range and near its 200-day simple moving average. Price change The price of RXRX shares has increased $0.02 since the market last closed. This is a 0.57% ...

The scalable web crawling and scraping library for JavaScript. Enables development of data extraction and web automation jobs (not only) with headless Chrome and Puppeteer. - ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Options data delayed by 15 minutes. For real-time data, try AlphaSpace .